The latest financial statement is for the year ending 2026-01-02.
| Cash Flow | 2026-01-02 |
|---|---|
| Net income | 106,009 |
| Depreciation and amortization of property, equipment and leasehold improvements | 10,083 |
| Provision for contract losses and doubtful accounts | 2,988 |
| Stock-based compensation | 23,795 |
| Deferred income tax provision | -9,948 |
| Accounts receivable | 23,088 |
| Prepaid expenses and other current assets | -7,678 |
| Change in operating leases | -3,229 |
| Accounts payable and accrued liabilities | 7,678 |
| Accrued payroll and employee benefits | 807 |
| Deferred revenues | 2,499 |
| Net cash provided by operating activities | 131,730 |
| Capital expenditures | 9,390 |
| Net cash used in investing activities | -9,390 |
| Payroll taxes for restricted stock units | 4,166 |
| Repurchase of common stock | 97,095 |
| Exercise of stock-based payment awards | 2,372 |
| Dividends and dividend equivalent rights | 61,539 |
| Net cash used in financing activities | -160,428 |
| Effect of foreign currency exchange rates on cash and cash equivalents | 1,117 |
| Net change in cash and cash equivalents | -36,971 |
| Cash and cash equivalents at beginning of year | 258,901 |
| Cash and cash equivalents at end of year | 221,930 |
EXPONENT INC (EXPO)
EXPONENT INC (EXPO)